- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 04.08. | Rapid Dose Therapeutics Corp.: Rapid Dose Therapeutics Submits QuickStrip Nicotine Product for Health Canada Approval | 325 | Newsfile | Burlington, Ontario--(Newsfile Corp. - August 4, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian life sciences company focused on innovative drug delivery technologies... ► Artikel lesen | |
| 29.07. | Rapid Dose Therapeutics Corp: Rapid Dose, Eco work on harm reduction pilot project | 2 | Stockwatch | ||
| RAPID DOSE THERAPEUTICS Aktie jetzt für 0€ handeln | |||||
| 29.07. | Rapid Dose Therapeutics Corp.: Rapid Dose Therapeutics and Eco Canadian Organic Inc. Initiate Health Canada Funded SUAP Harm Reduction Pilot Project on First Nations Using QuickStrip to Combat Opiate Addiction Crisis | 143 | Newsfile | Burlington, Ontario--(Newsfile Corp. - July 29, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian biotechnology company, is proud to announce the launch of a new... ► Artikel lesen | |
| 22.07. | CEO.CA Technologies Ltd.: CEO.CA's Inside the Boardroom: QuickStrip Technology - How Rapid Dose Is Changing The Way We Take Medicine | 500 | Newsfile | Toronto, Ontario--(Newsfile Corp. - July 22, 2025) - CEO.CA ("CEO.CA"), the leading investor social network in venture stocks, shares exclusive updates with CEOs and executives from around the globe.Founded... ► Artikel lesen | |
| 04.07. | Rapid Dose Therapeutics Corp: Rapid Dose to issue shares as fee payments to directors | 1 | Stockwatch | ||
| 03.07. | Rapid Dose Therapeutics Corp: Rapid Dose Therapeutics issues shares for interest | 2 | Stockwatch | ||
| 03.07. | Rapid Dose Therapeutics Corp.: Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt | 483 | Newsfile | Burlington, Ontario--(Newsfile Corp. - July 3, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that as contemplated in the secured convertible notes (the... ► Artikel lesen | |
| 03.07. | Rapid Dose Therapeutics Corp.: Rapid Dose Announces Proposed Issuance of Shares as Payment of Director Fees | 551 | Newsfile | Burlington, Ontario--(Newsfile Corp. - July 3, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announces that it has agreed with its non-management directors (the "Directors")... ► Artikel lesen | |
| 02.07. | CEO.CA Technologies Ltd.: CEO.CA's Inside the Boardroom: Rapid Dose's Drug Delivery Tech in NFL-Funded Study | 258 | Newsfile | Toronto, Ontario--(Newsfile Corp. - July 2, 2025) - CEO.CA ("CEO.CA"), the leading investor social network in venture stocks, shares exclusive updates with CEOs and executives from around the globe.Founded... ► Artikel lesen | |
| 03.06. | Rapid Dose Therapeutics Corp: Rapid Dose closes debt settlement, issues 1.88M shares | 2 | Stockwatch | ||
| 02.06. | Rapid Dose Therapeutics Corp.: Rapid Dose Announces Completion of Share Issuance in Debt Settlement with Creditors | 350 | Newsfile | Burlington, Ontario--(Newsfile Corp. - June 2, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") today announced that further to its press release dated May 10, 2025, it has... ► Artikel lesen | |
| 28.05. | PTA-News: Rapid Dose Therapeutics Inc.: Partnerschaft mit weltweit führendem Tabakhersteller | 285 | Dow Jones News | DJ PTA-News: Rapid Dose Therapeutics Inc.: Partnerschaft mit weltweit führendem Tabakhersteller
Unternehmensmitteilung für den Kapitalmarkt
Rapid Dose Therapeutics Inc.: Partnerschaft mit... ► Artikel lesen | |
| 28.05. | Rapid Dose Therapeutics Corp.: Partnerschaft mit weltweit führendem Tabakhersteller | 438 | IR-WORLD | BURLINGTON, ON - 26. Mai 2025 - Rapid Dose Therapeutics Corp. ("RDT" oder das "Unternehmen") (CSE: DOSE), ein kanadisches Biowissenschaftsunternehmen, das sich
auf innovative Lösungen für die... ► Artikel lesen | |
| 28.05. | Rapid Dose Therapeutics Corp: Rapid Dose arranges $3-million private placement | 3 | Stockwatch | ||
| 27.05. | Rapid Dose Therapeutics announces proposed equity private placement financing of up to $3M | 2 | Seeking Alpha | ||
| 27.05. | Rapid Dose Therapeutics Corp.: Rapid Dose Announces Proposed Equity Private Placement Financing | 377 | Newsfile | Burlington, Ontario--(Newsfile Corp. - May 27, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") today announced that it plans to complete an equity private placement financing... ► Artikel lesen | |
| 27.05. | Rapid Dose Therapeutics Corp: Rapid Dose files nicotine delivery patent applications | 4 | Stockwatch | ||
| 27.05. | Rapid Dose Therapeutics Corp.: Rapid Dose Therapeutics and Aavishkar Oral Strips File Two Key Patents for Innovative Nicotine Delivery Technology | 506 | Newsfile | Burlington, Ontario--(Newsfile Corp. - May 26, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian life sciences company specializing in innovative drug delivery... ► Artikel lesen | |
| 22.05. | CEO.CA Technologies Ltd.: CEO.CA's Inside the Boardroom: Rapid Dose Therapeutics Advances QuickStrip Technology for Use in Dentistry | 356 | Newsfile | Toronto, Ontario--(Newsfile Corp. - May 22, 2025) - CEO.CA ("CEO.CA"), the leading investor social network in venture stocks, shares exclusive updates with CEOs and executives from around the globe.Founded... ► Artikel lesen | |
| 16.05. | PTA-News: Rapid Dose Therapeutics Inc.: Rapid Dose Therapeutics entwickelt neues Anästhesie-Hilfsmittel für Zahnarztpraxen | 372 | Dow Jones News | DJ PTA-News: Rapid Dose Therapeutics Inc.: Rapid Dose Therapeutics entwickelt neues Anästhesie-Hilfsmittel für Zahnarztpraxen
Unternehmensmitteilung für den Kapitalmarkt
Rapid Dose Therapeutics... ► Artikel lesen |
1 2 3 Weiter >>
43 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BIONTECH | 96,40 | -0,05 % | Neues Zoll Drama - wie Novo Nordisk, Vidac Pharma und BioNTech mit KI und Onkologie dem Protektionismus begegnen | Die globale Pharmabranche erlebt 2025 eine historische Doppelrevolution: Künstliche Intelligenz beschleunigt Forschung und personalisierte Therapien, während disruptive US-Zölle von bis zu 250 % Lieferketten... ► Artikel lesen | |
| CLINUVEL | 7,000 | +0,86 % | CLINUVEL PHARMACEUTICALS LIMITED: Bioshares Biotech Summit presentation | ||
| BIONXT SOLUTIONS | 0,640 | -1,23 % | Plattform-Strategien krempeln Biotech-Markt um: BioNxt, Thermo Fisher Scientific, Evotec | Bei Biotech gilt längst nicht mehr das Prinzip alles oder nichts. Statt nur ein Produkt im Angebot zu haben, setzt sich bei der Entwicklung der Wirkstoffe von morgen die Plattform-Ökonomie durch. Was... ► Artikel lesen | |
| AMYRIS | - | - | Amyris gains sole control of Brazilian fermentation facility | ||
| ATAI LIFE SCIENCES | 3,487 | +0,61 % | Atai Life Sciences: NBC-Trader sacken +26% in Kürze ein! | Einmal mehr demonstriert Chefanalyst Maximilian Ruth sein Können und liefert Mitgliedern des No Brainer Club mit der Aktie von Atai Life Sciences satte zweistellige Kursgewinne in Windeseile. Empfehlung... ► Artikel lesen | |
| VIDAC PHARMA | 0,518 | 0,00 % | Achtung Übernahmen: Hier geht's rund! Bayer, Eli Lilly, Vidac Pharma, Formycon im Fokus | Volatilität ist Trumpf! Für Spekulanten aussichtsreich, für Investoren oft schwer zu handeln. Biotech-Aktien reagieren extrem sensibel auf Studien- und Zulassungsnachrichten, besonders in der Krebsforschung.... ► Artikel lesen | |
| SOL GLOBAL INVESTMENTS | 0,051 | +6,03 % | SOL Global Investments Corp.: SOL Global Announces Listing on OTC Markets Under OTCID: SOLCF | Toronto, Ontario--(Newsfile Corp. - July 22, 2025) - SOL Global Investments Corp. (CSE: SOL) (OTCID: SOLCF) (FSE: 9SB) ("SOL Global" or the "Company") is pleased to announce that its common shares... ► Artikel lesen | |
| MUSTGROW BIOLOGICS | 0,420 | -0,47 % | MustGrow Biologics Corp.: MustGrow Announces Non-Brokered LIFE Offering of up to $3 Million, Proposed Repricing of Warrants, and Shares for Debt Settlement Offer to Debentureholders | Saskatoon, Saskatchewan--(Newsfile Corp. - July 30, 2025) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), is pleased to announce the following: (i)... ► Artikel lesen | |
| ENTHEON BIOMEDICAL CORP | 0,050 | 0,00 % | Entheon Biomedical Corp.: Entheon Announces Change of Directors | Vancouver, British Columbia--(Newsfile Corp. - April 4, 2025) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU) ("Entheon" or the "Company") announces the appointment of Harrison Newlands... ► Artikel lesen | |
| TVARDI THERAPEUTICS | 19,600 | -2,97 % | XFRA 69C: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| REVIVE THERAPEUTICS | 0,010 | +900,00 % | Revive Therapeutics Ltd.: Revive Therapeutics Announces Closing of First Tranche of Private Placement and Debt Settlement | TORONTO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company dedicated to developing... ► Artikel lesen | |
| CYBIN | 6,450 | 0,00 % | Cybin Inc.: Cybin Receives European Approval for EMBRACE, a Multinational Phase 3 Study Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder | - EMBRACE, the second study within the Phase 3 PARADIGM program, will enroll 330 participants at approximately 60 clinical sites across the United States, Europe, the United Kingdom, and Australia... ► Artikel lesen | |
| ARTELO BIOSCIENCES | 9,720 | 0,00 % | Artelo Biosciences Receives Notice of Allowance from European Patent Office for the Patent Claims for the Intended Commercial Formulation of ART27.13 | Extends Patent Protection Through December 2041 ART27.13 is Currently under Evaluation in a Phase 2 Study for the Treatment of Cancer-Related Anorexia SOLANA BEACH, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| LOBE SCIENCES | 0,024 | +14,63 % | Lobe Sciences Ltd. Engages ArcStone Securities for Strategic Capital Markets Advisory | VANCOUVER, BC / ACCESS Newswire / July 29, 2025 / Lobe Sciences Ltd. (CSE:LOBE)(OTCQB:LOBEF)(FWB:LOBE.F), a biopharmaceutical company focused on developing therapeutics for rare and underserved diseases... ► Artikel lesen | |
| AVIDITY BIOSCIENCES | 46,150 | 0,00 % | Avidity Biosciences, Inc.: Avidity Biosciences Reports Second Quarter 2025 Financial Results and Recent Highlights | Aligned with FDA on del-brax accelerated and full approval pathways for FSHD, reported positive topline data from Phase 1/2 FORTITUDE trial, and initiated global... ► Artikel lesen |
Das Unternehmen RAPID DOSE THERAPEUTICS CORP kann der Branche Biotechnologie zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu RAPID DOSE THERAPEUTICS CORP finden Sie auf Wallstreet Online.